Martin Bollmark
Martin Bollmark has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Dmytro Honcharenko
Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden
1 shared publication - Kristina Karalė
Department of Biosciences and Nutrition, Karolinska Institutet, Neo, 141 57, Huddinge, Sweden
1 shared publication - Roger Strömberg
Department of Biosciences and Nutrition, Karolinska Institutet, Neo, 141 83 Huddinge, Sweden
1 shared publication - Rouven Stulz
Department of Biosciences and Nutrition, Karolinska Institutet, Neo, 141 57 Huddinge, Sweden
1 shared publication - Ulf Tedebark
RISE, Department Chemical Process and Pharmaceutical Development, Forskargatan 18, SE-15136 Södertälje, Sweden
1 shared publication
Latest Publications
- Open Access
A Study on Synthesis and Upscaling of 2′-O-AECM-5-methyl Pyrimidine Phosphoramidites for Oligonucleotide Synthesis
2′-O-(N-(Aminoethyl)carbamoyl)methyl-modified 5-methyluridine (AECM-MeU) and 5-methylcytidine (AECM-MeC) phosphoramidites are reported for the first time and prepared in multigram quantities. The syntheses of AECM-MeU and AECM-MeC nucleosides are designed for larger scales (approx. 20 g up until phosphoramidite preparation steps) using low-cost reagents and minimizing chromatographic purifications. Several steps were screened for best conditions, focusing on the most crucial steps such as N3 and/or 2′-OH alkylations, which were improved for larger scale synthesis using phase transfer catalysis (PTC). Moreover, the need of chromatographic purifications was substantially reduced by employing one-pot synthesis and improved work-up strategies.
Open AccessA Study on Synthesis and Upscaling of 2′-O-AECM-5-methyl Pyrimidine Phosphoramidites for Oligonucleotide Synthesis
2′-O-(N-(Aminoethyl)carbamoyl)methyl-modified 5-methyluridine (AECM-MeU) and 5-methylcytidine (AECM-MeC) phosphoramidites are reported for the first time and prepared in multigram quantities. The syntheses of AECM-MeU and AECM-MeC nucleosides are designed for larger scales (approx. 20 g up until phosphoramidite preparation steps) using low-cost reagents and minimizing chromatographic purifications. Several steps were screened for best conditions, focusing on the most crucial steps such as N3 and/or 2′-OH alkylations, which were improved for larger scale synthesis using phase transfer catalysis (PTC). Moreover, the need of chromatographic purifications was substantially reduced by employing one-pot synthesis and improved work-up strategies.